Promoter methylation status in breast tumors, adjacent normal tissues and blood from the same patients along with control blood samples were analyzed to correlate the effect of methylation with down regulation of RbL2/p130 gene in breast cancer patients (Fig 2). Here, RBL2 is linked to breast carcinoma.